Attovia Therapeutics, Inc.
ATTO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002058707
In the last 90 days, Attovia Therapeutics, Inc. insiders filed 5 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Members of Congress who traded ATTO
No member of Congress has reported a trade in Attovia Therapeutics, Inc. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.